FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

ELSKEN VAN DER WALL

Research Profile

Disorders

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Jeroen F Vermeulen; Arthur Adams; Willem P Th M Mali; Aram S A van Brussel; ELSKEN VAN DER WALL; Paul J van Diest; Patrick W B Derksen
Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study.
Michel D Wissing; ELSKEN VAN DER WALL; Paulus van Diest; Hans Gelderblom
Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer.
Liesbeth M van Vliet; Marij A Hillen; Nicole Plum; ELSKEN VAN DER WALL; Jozien M Bensing
How to create and administer scripted video-vignettes in an experimental study on disclosure of a palliative breast cancer diagnosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of ELSKEN VAN DER WALL (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jeroen F Vermeulen; Arthur Adams; Willem P Th M Mali; Aram S A van Brussel; ELSKEN VAN DER WALL; Paul J van Diest; Patrick W B Derksen
Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2013;15(3):290-8.
2013: Michel D Wissing; ELSKEN VAN DER WALL; Paulus van Diest; Hans Gelderblom
Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer.
Expert opinion on investigational drugs 2013;22(5):635-61.
2013: Liesbeth M van Vliet; Marij A Hillen; Nicole Plum; ELSKEN VAN DER WALL; Jozien M Bensing
How to create and administer scripted video-vignettes in an experimental study on disclosure of a palliative breast cancer diagnosis.
Patient education and counseling 2013;91(1):56-64.
2013: Liesbeth van Vliet; Anneke Francke; Nicole Plum; Samanta Tomson; ELSKEN VAN DER WALL; Jozien Bensing
When cure is no option: how explicit and hopeful can information be given? A qualitative study in breast cancer.
Patient education and counseling 2013;90(3):315-22.
2013: Miangela M Lacle; Carmen van der Pol; ELSKEN VAN DER WALL; Arjen Witkamp; Paulus van Diest
Prognostic value of mitotic index and Bcl2 expression in male breast cancer.
PloS one 2013;8(4):e60138.
2013: Petra van Der Groep; Rob B van der Luijt; Paulus van Diest; Margreet G E M Ausems; Joost Bart; Elisabeth G E de Vries; Fred H Menko; Yvonne H C M Smolders; ELSKEN VAN DER WALL
HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
PloS one 2013;8(2):e56055.
2013: Jeroen F Vermeulen; Robert Kornegoor; Petra van Der Groep; ELSKEN VAN DER WALL; Paulus van Diest
Differential expression of growth factor receptors and membrane-bound tumor markers for imaging in male and female breast cancer.
PloS one 2013;8(1):e53353.
2012: Cigdem Ercan; Laurien Hoefnagel; Petra van Der Groep; ELSKEN VAN DER WALL; Peter Bult; Jeroen F Vermeulen; Paulus van Diest
HIF-1α and NOTCH signaling in ductal and lobular carcinomas of the breast.
Cellular oncology (Dordrecht) 2012;35(6):435-42.
2012: Liesbeth M van Vliet; William Verheul; Akke Albada; Peter Spreeuwenberg; ELSKEN VAN DER WALL; Jozien M Bensing
The validity of using analogue patients in practitioner-patient communication research: systematic review and meta-analysis.
Journal of general internal medicine 2012;27(11):1528-43.
2012: Laurien D C Hoefnagel; S L Meijer; Cathy B Moelans; Iris D Nagtegaal; Joost Oudejans; Cornelis A Seldenrijk; Paul van der Valk; ELSKEN VAN DER WALL; Carla H van Gils; Henk-Jan van Slooten; Jelle Wesseling; Pieter Wesseling; Pieter J Westenend; Joost Bart; Paulus van Diest
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases.
Cancer 2012;118(20):4929-35.
2012: Paulus van Diest; Laurien D C Hoefnagel; ELSKEN VAN DER WALL
Testing for discordance at metastatic relapse of breast cancer matters.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(24):3031; author reply 3031-2, 3032-3.
2012: M Tenhagen; ELSKEN VAN DER WALL; Paulus van Diest; I A Ivanova; Petra van Der Groep
Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets.
Endocrine-related cancer 2012;19(4):R115-29.
2012: Cigdem Ercan; John Hinrichs; Bram van der Ende; ELSKEN VAN DER WALL; Paulus van Diest; Horst Buerger; Peter Bult; Patrick W B Derksen
p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast.
Cellular oncology (Dordrecht) 2012;35(2):111-8.
2012: Miranda J Velthuis; ELSKEN VAN DER WALL; Anne M May; Evelyn Monninkhof; Petra H M Peeters
Alternatives for randomization in lifestyle intervention studies in cancer patients were not better than conventional randomization.
Journal of clinical epidemiology 2012;65(3):288-92.
2012: Jeroen F Vermeulen; Peter Bult; Folkert H M Morsink; Aram S A van Brussel; Petra van Der Groep; ELSKEN VAN DER WALL; Paulus van Diest
Immunophenotyping invasive breast cancer: paving the road for molecular imaging.
BMC cancer 2012;12():240.
2012: Jeroen F Vermeulen; Peter Bult; Matthias Christgen; Juliet Daniel; Cigdem Ercan; Ulrich Lehmann; Robert A H van de Ven; Petra van Der Groep; ELSKEN VAN DER WALL; Paulus van Diest; Patrick W B Derksen
Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.
PloS one 2012;7(5):e37864.
2012: Doranne L Hilarius; Paul H Kloeg; Joris J G van den Heuvel; ELSKEN VAN DER WALL; Chad Gundy; Neil K Aaronson
Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(1):107-17.
2011: Agon Hyseni; Petra van Der Groep; ELSKEN VAN DER WALL; Paulus van Diest
Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression.
Cellular oncology (Dordrecht) 2011;34(6):565-70.
2011: Cathy Moelans; ELSKEN VAN DER WALL; Roel A de Weger; Paulus van Diest
Current technologies for HER2 testing in breast cancer.
Critical reviews in oncology/hematology 2011;80(3):380-92.
2011: Anoek H J Verschuur-Maes; Arjen J Witkamp; Peter C de Bruin; ELSKEN VAN DER WALL; Paulus van Diest
Progression risk of columnar cell lesions of the breast diagnosed in core needle biopsies.
International journal of cancer. Journal international du cancer 2011;129(11):2674-80.
2011: Laura M S Seeber; Nicole Horrée; Marc Vooijs; A Peter M Heintz; ELSKEN VAN DER WALL; René H M Verheijen; Paulus van Diest
The role of hypoxia inducible factor-1alpha in gynecological cancer.
Critical reviews in oncology/hematology 2011;78(3):173-84.
2011: Petra van Der Groep; ELSKEN VAN DER WALL; Paulus van Diest
Pathology of hereditary breast cancer.
Cellular oncology (Dordrecht) 2011;34(2):71-88.
2011: Doranne L Hilarius; Paul H Kloeg; ELSKEN VAN DER WALL; Manon Komen; Chad M Gundy; Neil K Aaronson
Cancer-related fatigue: clinical practice versus practice guidelines.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(4):531-8.
2011: Marise R Heerma van Voss; Petra van Der Groep; Joost Bart; ELSKEN VAN DER WALL; Paulus van Diest
Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.
Cellular oncology (Dordrecht) 2011;34(1):3-10.
2011: K P M Suijkerbuijk; Paulus van Diest; ELSKEN VAN DER WALL
Improving early breast cancer detection: focus on methylation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(1):24-9.
2010: Guus M Bol; Karijn P M Suijkerbuijk; Joost Bart; Marc Vooijs; ELSKEN VAN DER WALL; Paulus van Diest
Methylation profiles of hereditary and sporadic ovarian cancer.
Histopathology 2010;57(3):363-70.
2010: Marise R Heerma van Voss; Petra van Der Groep; Joost Bart; ELSKEN VAN DER WALL; Paulus van Diest
Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers.
Breast cancer research and treatment 2010;123(2):611-2.
2010: Karijn P M Suijkerbuijk; ELSKEN VAN DER WALL; Helen Meijrink; Xiaojuan Pan; Inne H M Borel Rinkes; Margreet G E M Ausems; Paulus van Diest
Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer.
Familial cancer 2010;9(3):321-5.
2010: B G Brouwer; Frank L J Visseren; Ale Algra; J H van Bockel; E L E M Bollen; Pieter A Doevendans; Jacoba P Greving; L Jaap Kappelle; Frans L Moll; Hanno Pijl; Johannes A Romijn; ELSKEN VAN DER WALL; Yolanda van der Graaf
Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative study.
Journal of internal medicine 2010;268(1):83-93.
2010: Bart van De Sluis; Xicheng Mao; Yali Zhai; Arjan J Groot; Jeroen F Vermeulen; ELSKEN VAN DER WALL; Paulus van Diest; Marten H Hofker; Cisca Wijmenga; Leo W Klomp; Kathleen R Cho; Eric R Fearon; Marc Vooijs; Ezra Burstein
COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.
The Journal of clinical investigation 2010;120(6):2119-30.
2010: Paulus van Diest; Karijn P M Suijkerbuijk; Esther A Koop; Roel A de Weger; ELSKEN VAN DER WALL
Low levels of BNIP3 promoter hypermethylation in invasive breast cancer.
Analytical cellular pathology (Amsterdam) 2010;33(3):175-6.
2010: Karijn P M Suijkerbuijk; Xiaojuan Pan; ELSKEN VAN DER WALL; Paulus van Diest; Marc Vooijs
Comparison of different promoter methylation assays in breast cancer.
Analytical cellular pathology (Amsterdam) 2010;33(3):133-41.
2010: Laurien D C Hoefnagel; Iris D Nagtegaal; Joost Oudejans; Cornelis A Seldenrijk; Marc J van de Vijver; Petra van Der Groep; Paul van der Valk; ELSKEN VAN DER WALL; Henk-Jan van Slooten; Jelle Wesseling; Pieter Wesseling; Pieter J Westenend; Joost Bart; Elisabeth G E de Vries; Paulus van Diest
Receptor conversion in distant breast cancer metastases.
Breast cancer research : BCR 2010;12(5):R75.
2010: Laura M S Seeber; Nicole Horrée; Petra van Der Groep; ELSKEN VAN DER WALL; René H M Verheijen; Paulus van Diest
Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
BMC cancer 2010;10():307.
2010: Miranda J Velthuis; Anne M May; Ria Ag Koppejan-Rensenbrink; Brigitte C M Gijsen; Eric van Breda; ardine de wit; Carin D Schröder; Evelyn Monninkhof; Eline Lindeman; ELSKEN VAN DER WALL; Petra H M Peeters
Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial.
BMC cancer 2010;10():272.
2010: Marise R Heerma van Voss; Petra van Der Groep; Jos Bart; ELSKEN VAN DER WALL; Paulus van Diest
Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls.
BMC cancer 2010;10():145.
2010: Cathy Moelans; Roel A de Weger; Marja T M van Blokland; ELSKEN VAN DER WALL; Paulus van Diest
Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(1):62-70.
2009: Carolien van Deurzen; Birgit E P J Vriens; Vivianne C G Tjan-Heijnen; ELSKEN VAN DER WALL; Mirjam Albregts; Richard van Hilligersberg; Evelyn M Monninkhof; Paulus van Diest
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review.
European journal of cancer (Oxford, England : 1990) 2009;45(18):3124-30.
2009: Geert van Tetering; Paulus van Diest; Ingrid Verlaan; ELSKEN VAN DER WALL; Raphael Kopan; Marc Vooijs
Metalloprotease ADAM10 is required for Notch1 site 2 cleavage.
The Journal of biological chemistry 2009;284(45):31018-27.
2009: T H Oude Munnink; W B Nagengast; A H Brouwers; Carolien P Schröder; Geke A P Hospers; Marjolijn N Lub-de Hooge; ELSKEN VAN DER WALL; Paulus van Diest; E G E de Vries
Molecular imaging of breast cancer.
Breast (Edinburgh, Scotland) 2009;18 Suppl 3():S66-73.
2009: Rob C M van Kruijsdijk; ELSKEN VAN DER WALL; Frank L J Visseren
Obesity and cancer: the role of dysfunctional adipose tissue.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(10):2569-78.
2009: Petra van Der Groep; Paulus van Diest; Fred H Menko; J Bart; E G E de Vries; ELSKEN VAN DER WALL
Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers.
Journal of clinical pathology 2009;62(10):926-30.
2009: Arjan J Groot; Mohamed El Khattabi; Norman Sachs; Petra van Der Groep; ELSKEN VAN DER WALL; Paulus van Diest; Arnoud Sonnenberg; C Theo Verrips; Marc Vooijs
Reverse proteomic antibody screening identifies anti adhesive VHH targeting VLA-3.
Molecular immunology 2009;46(10):2022-8.
2009: Bart van De Sluis; Arjan J Groot; Jeroen Vermeulen; ELSKEN VAN DER WALL; Paulus van Diest; Cisca Wijmenga; Leo W J Klomp; Marc Vooijs
COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.
PloS one 2009;4(10):e7332.
2009: Arno Kuijper; Antoine M Snijders; Petronella Berns; Vibeke Kuenen-Boumeester; ELSKEN VAN DER WALL; Donna G Albertson; Paulus van Diest
Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(1):31-9.
2008: Eh Gort; Karijn P M Suijkerbuijk; Suzan M Roothaan; Venu Raman; Marc Vooijs; ELSKEN VAN DER WALL; Paulus van Diest
Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(12):3325-30.
2008: Carolien van Deurzen; Maaike de Boer; Evelyn M Monninkhof; Peter Bult; ELSKEN VAN DER WALL; Vivianne C G Tjan-Heijnen; Paulus van Diest
Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node.
Journal of the National Cancer Institute 2008;100(22):1574-80.
2008: Nanda Krak; Jacobus van der Hoeven; Otto Hoekstra; Jos Twisk; ELSKEN VAN DER WALL; Adriaan Lammertsma
Blood flow and glucose metabolism in stage IV breast cancer: heterogeneity of response during chemotherapy.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2008;10(6):356-63.
2008: K P M Suijkerbuijk; Mary Jo Fackler; Saraswati Sukumar; C H van Gils; Teus-Jan van Laar; ELSKEN VAN DER WALL; Marc Vooijs; Paulus van Diest
Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(11):1870-4.
2008: P Nieboer; E G E de Vries; N H Mulder; S Rodenhuis; M Bontenbal; ELSKEN VAN DER WALL; Q G van Hoesel; W M Smit; P Hupperets; E E Voest; M A Nooij; H M Boezen; W T A van der Graaf
Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.
Bone marrow transplantation 2008;42(7):475-81.
2008: Petra van Der Groep; Alwin Bouter; Fred H Menko; ELSKEN VAN DER WALL; Paulus van Diest
High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.
Breast cancer research and treatment 2008;111(3):475-80.
2008: Jan P A Baak; Paulus van Diest; Emiel Janssen; einar gudlaugsson; Feja J Voorhorst; ELSKEN VAN DER WALL; Jan B Vermorken
Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):649-54.
2008: Eh Gort; G van Haaften; I Verlaan; Arjan J Groot; Ronald H Plasterk; Avi Shvarts; K P M Suijkerbuijk; Teus-Jan van Laar; ELSKEN VAN DER WALL; Venu Raman; Paulus van Diest; M Tijsterman; Marc Vooijs
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha.
Oncogene 2008;27(11):1501-10.
2008: Eh Gort; Arjan J Groot; ELSKEN VAN DER WALL; Paulus van Diest; Marc A Vooijs
Hypoxic regulation of metastasis via hypoxia-inducible factors.
Current molecular medicine 2008;8(1):60-7.
2008: Arjan J Groot; Eh Gort; ELSKEN VAN DER WALL; Paulus van Diest; Marc Vooijs
Conditional inactivation of HIF-1 using intrabodies.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2008;30(5):397-409.
2008: Karijn P M Suijkerbuijk; ELSKEN VAN DER WALL; Marc Vooijs; Paulus van Diest
Molecular analysis of nipple fluid for breast cancer screening.
Pathobiology : journal of immunopathology, molecular and cellular biology 2008;75(2):149-52.
2007: Arjan J Groot; Asferd Mengesha; ELSKEN VAN DER WALL; Paulus van Diest; Jan Theys; Marc Vooijs
Functional antibodies produced by oncolytic clostridia.
Biochemical and biophysical research communications 2007;364(4):985-9.
2007: Ciska Buijs; Sjoerd Rodenhuis; Caroline M Seynaeve; Q G C M van Hoesel; ELSKEN VAN DER WALL; Wim J M Smit; Marianne A Nooij; Emile E Voest; Pierre Hupperets; Elisabeth M TenVergert; Harm van Tinteren; P H B Willemse; Marian J E Mourits; Neil K Aaronson; Wendy J Post; Elisabeth G E de Vries
Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5403-9.
2007: K P M Suijkerbuijk; ELSKEN VAN DER WALL; Paulus van Diest
Oxytocin: bringing magic into nipple aspiration.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1743-4.
2007: K P M Suijkerbuijk; ELSKEN VAN DER WALL; Teus-Jan van Laar; Marc Vooijs; Paulus van Diest
[Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
Nederlands tijdschrift voor geneeskunde 2007;151(16):907-13.
2007: Jan P A Baak; Paulus van Diest; Feja J Voorhorst; ELSKEN VAN DER WALL; Louk V A M Beex; Jan B Vermorken; Emiel Janssen; einar gudlaugsson
The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.
European journal of cancer (Oxford, England : 1990) 2007;43(3):527-35.
2006: Juliane Hannemann; Petra M P Kristel; Harm van Tinteren; Marijke Bontenbal; Q G C M van Hoesel; W M Smit; Marianne A Nooij; Emile E Voest; ELSKEN VAN DER WALL; Pierre Hupperets; E G E de Vries; Sjoerd Rodenhuis; Marc J van de Vijver
Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy.
British journal of cancer 2006;95(10):1334-41.
2006: Eh Gort; Arjan J Groot; T L P Derks van de Ven; Petra van Der Groep; I Verlaan; Teus-Jan van Laar; Paulus van Diest; ELSKEN VAN DER WALL; Avi Shvarts
Hypoxia-inducible factor-1alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas.
Oncogene 2006;25(45):6123-7.
2006: Marije M Vleugel; David Shvarts; ELSKEN VAN DER WALL; Paulus van Diest
p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Human pathology 2006;37(8):1085-92.
2006: Marije M Vleugel; Astrid E Greijer; Reinhard Bos; ELSKEN VAN DER WALL; Paulus van Diest
c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer.
Human pathology 2006;37(6):668-74.
2006: Petra van Der Groep; A Bouter; R van der Zanden; I Siccama; Fred H Menko; J J P Gille; C van Kalken; ELSKEN VAN DER WALL; René H M Verheijen; Paulus van Diest
Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data.
Journal of clinical pathology 2006;59(6):611-7.
2006: Arjan J Groot; Peter Verheesen; Elike J Westerlaken; Eh Gort; Petra van Der Groep; Niels Bovenschen; ELSKEN VAN DER WALL; Paulus van Diest; Avi Shvarts
Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha.
Laboratory investigation; a journal of technical methods and pathology 2006;86(4):345-56.
2006: Sjoerd Rodenhuis; Marijke Bontenbal; Q G C M van Hoesel; W M Smit; Marianne A Nooij; Emile E Voest; ELSKEN VAN DER WALL; Pierre Hupperets; Harm van Tinteren; Johannes L Peterse; Marc J van de Vijver; E G E de Vries
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):588-96.
2006: Paulus van Diest; Petra van Der Groep; ELSKEN VAN DER WALL
EGFR expression predicts BRCA1 status in patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):670; author reply 671.
2005: Marije M Vleugel; Astrid E Greijer; ELSKEN VAN DER WALL; Paulus van Diest
Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer.
Cancer genetics and cytogenetics 2005;163(2):168-72.
2005: Peter Nieboer; Ciska Buijs; Sjoerd Rodenhuis; Caroline Seynaeve; Louk V A M Beex; ELSKEN VAN DER WALL; Dick J Richel; Marianne A Nooij; Emile E Voest; Pierre Hupperets; Nanno H Mulder; Winette T A van der Graaf; Elisabeth M TenVergert; Harm van Tinteren; Elisabeth G E de Vries
Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8296-304.
2005: H E Westerveld; J W Briet; E S Houwaart; J Legemaate; Th J A M Meerman; Elemi Breetvelt; ELSKEN VAN DER WALL
Dutch medical oath.
The Netherlands journal of medicine 2005;63(9):368-72.
2005: Jan P A Baak; Paulus van Diest; Feja J Voorhorst; ELSKEN VAN DER WALL; Louk V A M Beex; Jan B Vermorken; Emiel Janssen
Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5993-6001.
2005: Astrid E Greijer; Petra van Der Groep; D Kemming; Avi Shvarts; Gregg L Semenza; Gerrit A Meijer; Mark A van de Wiel; Jeroen A M Belien; Paulus van Diest; ELSKEN VAN DER WALL
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1).
The Journal of pathology 2005;206(3):291-304.
2005: Arno Kuijper; Rob A I de Vos; Jaap H Lagendijk; ELSKEN VAN DER WALL; Paulus van Diest
Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
American journal of clinical pathology 2005;123(5):690-8.
2005: Paulus van Diest; Marije M Vleugel; Petra van Der Groep; ELSKEN VAN DER WALL
VEGF-D and HIF-1alpha in breast cancer.
Journal of clinical pathology 2005;58(3):335; author reply 336.
2005: Paulus van Diest; Marije M Vleugel; ELSKEN VAN DER WALL
Expression of HIF-1alpha in human tumours.
Journal of clinical pathology 2005;58(3):335-6.
2005: Marije M Vleugel; Astrid E Greijer; Avi Shvarts; Petra van Der Groep; Maria P A van Berkel; Y Aarbodem; H van Tinteren; Adrian L Harris; Paulus van Diest; ELSKEN VAN DER WALL
Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Journal of clinical pathology 2005;58(2):172-7.
2005: Arno Kuijper; Petra van Der Groep; ELSKEN VAN DER WALL; Paulus van Diest
Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Breast cancer research : BCR 2005;7(5):R808-18.
2005: Astrid E Greijer; Mariska C de Jong; George L Scheffer; Avi Shvarts; Paulus van Diest; ELSKEN VAN DER WALL
Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2005;27(1):43-9.
2005: Reinhard Bos; Paulus van Diest; JS De Jong; Petra van Der Groep; Paul Van Der Valk; ELSKEN VAN DER WALL
Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer.
Histopathology 2005;46(1):31-6.
2004: Astrid E Greijer; ELSKEN VAN DER WALL
The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis.
Journal of clinical pathology 2004;57(10):1009-14.
2004: Ian F Faneyte; Johannes L Peterse; Harm van Tinteren; Corina Pronk; Marijke Bontenbal; Louk V A M Beex; ELSKEN VAN DER WALL; Dick J Richel; Marianne A Nooij; Emile E Voest; Pierre Hupperets; Elisabeth M Ten Vergert; Elisabeth G E de Vries; Sjoerd Rodenhuis; Marc J van de Vijver
Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4457-63.
2004: Marije M Vleugel; Reinhard Bos; Petra van Der Groep; Astrid E Greijer; Avi Shvarts; H V Stel; ELSKEN VAN DER WALL; Paulus van Diest
Lack of lymphangiogenesis during breast carcinogenesis.
Journal of clinical pathology 2004;57(7):746-51.
2004: Paulus van Diest; ELSKEN VAN DER WALL; Jan P A Baak
Prognostic value of proliferation in invasive breast cancer: a review.
Journal of clinical pathology 2004;57(7):675-81.
2004: Petra van Der Groep; Alwin Bouter; Richard van der Zanden; Fred H Menko; Horst Buerger; René H M Verheijen; ELSKEN VAN DER WALL; Paulus van Diest
Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.
Journal of the National Cancer Institute 2004;96(9):712-3; author reply 714.
2004: Eberhard Korsching; Jens Packeisen; Mike W Helms; Christian Kersting; Reinhard Voss; Paulus van Diest; Burkhard Brandt; ELSKEN VAN DER WALL; Werner Boecker; Horst Bürger
Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry.
British journal of cancer 2004;90(7):1422-8.
2004: Jacobus J M van Der Hoeven; Nanda C Krak; Otto S Hoekstra; Emile F I Comans; Robert P A Boom; Dick van Geldere; Sybren Meijer; ELSKEN VAN DER WALL; Jan Buter; HERBERT PINEDO; Gerrit J J Teule; Adriaan A Lammertsma
18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1253-9.
2004: Marije M Vleugel; Reinhard Bos; Horst Buerger; Petra van Der Groep; Outi Saramäki; Tapio Visakorpi; ELSKEN VAN DER WALL; Paulus van Diest
No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2004;26(5-6):347-51.
2004: Reinhard Bos; Paulus van Diest; Petra van Der Groep; Avi Shvarts; Astrid E Greijer; ELSKEN VAN DER WALL
Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related.
Breast cancer research : BCR 2004;6(4):R450-9.
2003: Reinhard Bos; Paulus van Diest; Petra van Der Groep; Astrid E Greijer; Mario A J A Hermsen; Ingrid Heijnen; Gerrit A Meijer; Jan P A Baak; HERBERT PINEDO; ELSKEN VAN DER WALL; Avi Shvarts
Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1alpha (HIF-1alpha).
Oncogene 2003;22(55):8948-51.
2003: HERBERT PINEDO; Jan Buter; Sylvia A Luykx-de Bakker; Paula R Pohlmann; Yvette van Hensbergen; D A M Heideman; Paulus van Diest; Tanja D de Gruijl; ELSKEN VAN DER WALL
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells.
European journal of cancer (Oxford, England : 1990) 2003;39(8):1061-7.
2003: Nanda C Krak; Jacobus J M van Der Hoeven; Otto S Hoekstra; Jos W R Twisk; ELSKEN VAN DER WALL; Adriaan A Lammertsma
Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.
European journal of nuclear medicine and molecular imaging 2003;30(5):674-81.
2003: Reinhard Bos; Petra van Der Groep; Astrid E Greijer; Avi Shvarts; Sybren Meijer; HERBERT PINEDO; Gregg L Semenza; Paulus van Diest; ELSKEN VAN DER WALL
Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Cancer 2003;97(6):1573-81.
2003: Monique C A Duyndam; Saskia T M Hulscher; ELSKEN VAN DER WALL; HERBERT PINEDO; Epie Boven
Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite.
The Journal of biological chemistry 2003;278(9):6885-95.
2002: Fransien de Boer; Angelika M Dräger; HERBERT PINEDO; Floortje L Kessler; M Monnee-van Muijen; G W D Weijers; Guus Westra; ELSKEN VAN DER WALL; Tanja Netelenbos; Jan W Oberink; Peter C Huijgens; Gerrit J Schuurhuis
Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts.
Journal of hematotherapy & stem cell research 2002;11(6):951-63.
2002: Arno Kuijper; S S Preisler-Adams; Frans D Rahusen; J J P Gille; ELSKEN VAN DER WALL; Paulus van Diest
Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ovarian cancer.
Journal of clinical pathology 2002;55(10):795-7.
2002: Arno Kuijper; Horst Buerger; Ronald Simon; Karl-Ludwig Schaefer; Anita Croonen; Werner Boecker; ELSKEN VAN DER WALL; Paulus van Diest
Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay.
The Journal of pathology 2002;197(5):575-81.
2002: Fransien de Boer; Floortje L Kessler; Tanja Netelenbos; Sonja Zweegman; Peter C Huijgens; ELSKEN VAN DER WALL; Jan A M van der Linden; HERBERT PINEDO; Gerrit J Schuurhuis; Angelika M Dräger
Homing and clonogenic outgrowth of CD34(+) peripheral blood stem cells: a role for L-selectin?
Experimental hematology 2002;30(6):590-7.
2002: Fransien de Boer; Angelika M Dräger; HERBERT PINEDO; Floortje L Kessler; ELSKEN VAN DER WALL; Andries R Jonkhoff; Johannes Van Der Lelie; Peter C Huijgens; Gert Ossenkoppele; Gerrit J Schuurhuis
Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
Bone marrow transplantation 2002;29(3):249-55.
2002: Reinhard Bos; Jacobus J M van Der Hoeven; ELSKEN VAN DER WALL; Petra van Der Groep; Paulus van Diest; Emile F I Comans; Urvi Joshi; Gregg L Semenza; Otto S Hoekstra; Adriaan A Lammertsma; Carla F M Molthoff
Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):379-87.
2002: Evelien Bodar; Jan Buter; Tanja D de Gruijl; ELSKEN VAN DER WALL; HERBERT PINEDO
Immunologic and biologic properties of the primary tumor during prolonged neoadjuvant chemoimmunotherapy.
Oncology (Williston Park, N.Y.) 2002;16(1 Suppl 1):32-9.
2001: Allan Hess; Christopher J Thoburn; WEIRAN CHEN; Yuji Miura; ELSKEN VAN DER WALL
The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigen.
Clinical immunology (Orlando, Fla.) 2001;101(1):67-76.
2001: Frans D Rahusen; Hans Torrenga; Paulus van Diest; Rik Pijpers; ELSKEN VAN DER WALL; J Licht; Sybren Meijer
Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer.
Archives of surgery (Chicago, Ill. : 1960) 2001;136(9):1059-63.
2001: Arno Kuijper; EC Mommers; ELSKEN VAN DER WALL; Paulus van Diest
Histopathology of fibroadenoma of the breast.
American journal of clinical pathology 2001;115(5):736-42.
2001: R Bos; Hua Zhong; CF Hanrahan; EC Mommers; Gregg L Semenza; HERBERT PINEDO; M D Abeloff; J W Simons; Paulus van Diest; ELSKEN VAN DER WALL
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.
Journal of the National Cancer Institute 2001;93(4):309-14.
2000: Fransien de Boer; Angelika M Dräger; M J Van Haperen; ELSKEN VAN DER WALL; Floortje L Kessler; Peter C Huijgens; HERBERT PINEDO; Gerrit J Schuurhuis
The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens.
British journal of haematology 2000;111(4):1138-44.
2000: ELSKEN VAN DER WALL; T Horn; Emilie C Bright; J L Passos-Coehlo; S Bond; B Clarke; VL Altomonte; K McIntyre; Georgia B Vogelsang; Stephen J Noga; JANICE DAVIS SPROUL; J Thomassen; KV Ohly; S M Lee; John H Fetting; Deborah K Armstrong; Nancy E Davidson; Allan Hess; M John Kennedy
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
British journal of cancer 2000;83(11):1405-11.
2000: HERBERT PINEDO; Tanja D de Gruijl; ELSKEN VAN DER WALL; Jan Buter
Biological concepts of prolonged neoadjuvant treatment plus GM-CSF in locally advanced tumors.
The oncologist 2000;5(6):497-500.
1999: ELSKEN VAN DER WALL
The sentinel node in breast cancer: implications for adjuvant treatment?
European journal of nuclear medicine 1999;26(4 Suppl):S17-9.
1999: Aafke H Honkoop; Sylvia A Luykx-de Bakker; Klaas Hoekman; S Meyer; O W Meyer; Cees J van Groeningen; Paulus van Diest; Epie Boven; ELSKEN VAN DER WALL; Giuseppe Giaccone; John Wagstaff; HERBERT PINEDO
Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer.
The oncologist 1999;4(2):106-11.
1998: Fransien de Boer; Angelika M Dräger; ELSKEN VAN DER WALL; HERBERT PINEDO; Gerrit J Schuurhuis
Changes in L-selectin expression on CD34-positive cells upon cryopreservation of peripheral blood stem cell transplants.
Bone marrow transplantation 1998;22(11):1103-10.
1998: Sjoerd Rodenhuis; Dick J Richel; ELSKEN VAN DER WALL; Jan H Schornagel; Joke W Baars; C C Koning; Johannes L Peterse; Jacques H Borger; Willem Nooijen; Roel Bakx; Otilia Dalesio; E J Th Rutgers
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
Lancet 1998;352(9127):515-21.
1997: Aafke H Honkoop; ELSKEN VAN DER WALL; Nicole Feller; Gerrit J Schuurhuis; Wim J F van der Vijgh; Epie Boven; Cees J van Groeningen; Giuseppe Giaccone; Klaas Hoekman; Jan B Vermorken; John Wagstaff; HERBERT PINEDO
Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(10):957-62.
1996: ELSKEN VAN DER WALL; C C Schaake-Koning; nico van zandwijk; Joke W Baars; Jan H Schornagel; Dick J Richel; E J Th Rutgers; Jacques H Borger; Jos H Beijnen; Sjoerd Rodenhuis
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis.
European journal of cancer (Oxford, England : 1990) 1996;32A(9):1490-7.
1996: ELSKEN VAN DER WALL; E J Th Rutgers; M J Holtkamp; Joke W Baars; Jan H Schornagel; Johannes L Peterse; Jos H Beijnen; Sjoerd Rodenhuis
Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.
British journal of cancer 1996;73(9):1080-5.
1996: Sjoerd Rodenhuis; Anneke M Westermann; M J Holtkamp; Willem Nooijen; Joke W Baars; ELSKEN VAN DER WALL; Ineke Slaper-Cortenbach; Jan H Schornagel
Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1473-83.
1996: LJ van Warmerdam; Sjoerd Rodenhuis; ELSKEN VAN DER WALL; R A Maes; Jos H Beijnen
Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support.
British journal of cancer 1996;73(8):979-84.
1995: M W Dercksen; Sjoerd Rodenhuis; M K Dirkson; Wim Schaasberg; Joke W Baars; ELSKEN VAN DER WALL; Ineke Slaper-Cortenbach; HERBERT PINEDO; A E Von dem Borne; C Ellen van der Schoot
Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1922-32.
1995: ELSKEN VAN DER WALL; Willem Nooijen; Joke W Baars; M J Holtkamp; J H Schorangel; Dick J Richel; E J Th Rutgers; Ineke Slaper-Cortenbach; C Ellen van der Schoot; Sjoerd Rodenhuis
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.
British journal of cancer 1995;71(4):857-62.
1995: ELSKEN VAN DER WALL; Jos H Beijnen; Sjoerd Rodenhuis
High-dose chemotherapy regimens for solid tumors.
Cancer treatment reviews 1995;21(2):105-32.
1995: Sjoerd Rodenhuis; ELSKEN VAN DER WALL; Wim W ten Bokkel Huinink; Jan H Schornagel; Dick J Richel; L T Vlasveld
Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancer.
Cancer investigation 1995;13(4):355-62.
1994: ELSKEN VAN DER WALL; Dick J Richel; M J Holtkamp; Ineke Slaper-Cortenbach; C Ellen van der Schoot; Otilia Dalesio; Willem Nooijen; Jan H Schornagel; Sjoerd Rodenhuis
Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):795-802.
1993: Dick J Richel; ELSKEN VAN DER WALL; J Slaper; E Van der Schoot; Sjoerd Rodenhuis
Peripheral blood stem cell (PBSC) mobilization and transplantation (PSCT) in patients with malignant lymphomas and solid tumors.
The International journal of artificial organs 1993;16 Suppl 5():71-5.
1993: ELSKEN VAN DER WALL; Dick J Richel; Y H Kusumanto; E J Th Rutgers; Jan H Schornagel; C C Schaake-Koning; Johannes L Peterse; Sjoerd Rodenhuis
Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):791-2.
1993: ELSKEN VAN DER WALL; T H Donker; E de Frankrijker; H W Nortier; Jos H H Thijssen; Marinus A Blankenstein
Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women.
Cancer research 1993;53(19):4563-6.
1992: M W Bots; H J Dijkstra; G H Blijham; ELSKEN VAN DER WALL; M C Fehmers; H J Keizer; J W Nortier; L Siegenbeek van Heukelom; Peter Slee; C H Veenhof
A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational study.
The Netherlands journal of medicine 1992;40(5-6):221-6.
1992: ELSKEN VAN DER WALL; Roel P Verkooyen; J Mintjes-de Groot; J Oostinga; A van Dijk; W N Hustinx; Henri A Verbrugh
Prophylactic ciprofloxacin for catheter-associated urinary-tract infection.
Lancet 1992;339(8799):946-51.
1990: M B Garcia; M A Blankenstein; ELSKEN VAN DER WALL; J W Nortier; Jan Schornagel; J H Thijssen
Comparison of breast cancer mucin (BCM) and CA 15-3 in human breast cancer.
Breast cancer research and treatment 1990;17(2):69-76.